发明名称 |
Compositions and methods of treating cancer using compositions comprising an inhibitor of endothelin receptor activity |
摘要 |
Described herein are results which show that an endothelin receptor antagonist, BQ788, increases pigmentation and significantly reduces the viability of 7 human melanoma cell lines in culture. Moreover, it is described herein that administration of BQ788 significantly slows melanoma tumor growth in nude mice, including a complete growth arrest in half of the mice treated systemically. Thus, inhibitors of endothelin receptor activity are described herein as beneficial for the treatment of cancer. |
申请公布号 |
AU6065000(A) |
申请公布日期 |
2001.01.31 |
申请号 |
AU20000060650 |
申请日期 |
2000.06.29 |
申请人 |
CALIFORNIA INSTITUTE OF TECHNOLOGY |
发明人 |
PAUL H. PATTERSON;RONIT LAHAV |
分类号 |
A61K38/06;A61K38/22;A61K47/48;A61P35/00 |
主分类号 |
A61K38/06 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|